How is Sjogren's syndrome diagnosed in a patient with Rheumatoid Arthritis (RA) and symptoms of dry eyes and burning mouth pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Sjögren's Syndrome

Sjögren's syndrome is diagnosed using a weighted scoring system requiring ≥4 points from objective criteria: anti-SSA/Ro antibody positivity (3 points), focal lymphocytic sialadenitis on minor salivary gland biopsy with focus score ≥1 foci/4 mm² (3 points), abnormal ocular staining score ≥5 (1 point), Schirmer test ≤5 mm/5 minutes (1 point), or unstimulated salivary flow rate ≤0.1 ml/minute (1 point). 1

Clinical Suspicion and Initial Assessment

Maintain high suspicion for Sjögren's syndrome in any patient with both clinically significant dry eye and dry mouth symptoms. 2 Approximately 10% of patients with clinically significant aqueous deficient dry eye have underlying primary Sjögren's syndrome. 1

Key Symptoms to Elicit:

Dry Eye Manifestations:

  • Foreign body sensation, eye irritation, itchiness, or pain 1
  • Light sensitivity 1
  • Frequent use of eye drops for irritation or dryness 1

Dry Mouth Manifestations:

  • Need for liquids to swallow dry foods 1
  • Frequent sipping/drinking of water 1
  • Burning sensation in mouth 1
  • Angular cheilitis (painful sores or red patches at corners of mouth) 1
  • Frequent dental cavities and gum inflammation 1

Systemic Symptoms:

  • Joint pain (arthralgias) and muscle pain (myalgias) 1
  • Extreme fatigue 1
  • Peripheral neuropathy (numbness, burning pain in extremities) 1
  • Dry, nonproductive cough 1

Physical Examination Findings

Slit-Lamp Biomicroscopy:

  • Reduced tear meniscus height along inferior eyelid 2
  • Abnormal tear break-up time and pattern 2
  • Punctate staining with fluorescein, lissamine green, or rose bengal dyes on conjunctiva and cornea 2
  • Lissamine green staining of conjunctiva may aid in early diagnosis 2

External Examination:

  • Enlargement of lacrimal glands 2
  • Joint deformities characteristic of rheumatoid arthritis (ulnar deviation of fingers) 2
  • Raynaud phenomenon 2

Serological Testing

Order a complete serological panel when Sjögren's syndrome is suspected: 1, 3

  • Anti-SSA/Ro antibody (most important—scores 3 points if positive) 1
  • Anti-SSB/La antibody 3
  • Rheumatoid factor (RF) 2, 3
  • Antinuclear antibody (ANA) 3

Critical Note: Anti-SSA/Ro antibody positivity is the single most valuable serological marker, but a negative result does NOT exclude Sjögren's syndrome—diagnosis can still be made with ≥4 points from other objective criteria. 1

Objective Diagnostic Tests

Ocular Surface Testing:

  • Schirmer test without anesthesia: ≤5 mm/5 minutes scores 1 point 1
  • Ocular staining score: ≥5 (or van Bijsterveld score ≥4) scores 1 point 1
  • Tear film osmolarity measurement using FDA-approved devices 1
  • Point-of-care matrix metalloproteinase-9 testing for inflammatory dry eye 1

Salivary Gland Assessment:

  • Unstimulated whole salivary flow rate: ≤0.1 ml/minute scores 1 point 1
  • Minor salivary gland biopsy if clinical suspicion remains high: focal lymphocytic sialadenitis with focus score ≥1 foci/4 mm² scores 3 points 1

Point-of-Care Salivary Biomarkers:

  • Salivary protein 1 (SP1), carbonic anhydrase 6 (CA6), and parotid secretory protein (PSP) may indicate early Sjögren's syndrome, though additional validation studies are needed 1

Classification: Primary vs. Secondary Sjögren's Syndrome

  • Primary Sjögren's syndrome: Occurs alone as a distinct entity 1
  • Secondary Sjögren's syndrome: Occurs with another autoimmune disease such as rheumatoid arthritis, systemic lupus erythematosus, or scleroderma 1, 4

In your patient with RA and dry eyes/burning mouth, you are evaluating for secondary Sjögren's syndrome. 5

Mandatory Rheumatology Referral

Co-management with a rheumatologist is essential due to: 1

  • Approximately 5% lifetime risk of developing lymphoma (320 cases per 100,000 patient-years increased incidence) 1
  • Decreased C4 levels at diagnosis indicate higher lymphoma risk 1, 3
  • Potential for life-threatening vasculitic or lymphoproliferative disorders 1
  • Need for systemic immunosuppressive therapy for extraglandular manifestations 1

Important Caveats

Differential Diagnoses to Consider:

  • HCV-related sicca syndrome (differentiated by absence of anti-SSA/SSB antibodies) 3
  • Checkpoint inhibitor-induced sicca syndrome (only 20% anti-Ro positive with distinct histological patterns) 3
  • Medication-induced dry eyes/mouth (antihistamines, diuretics, antidepressants, anticholinergics) 2

Special Considerations:

  • In women of childbearing age with positive anti-Ro/SSA antibodies, counsel about risk of neonatal lupus and congenital heart block 3
  • Anti-Ro/SSA antibodies can be present in systemic lupus erythematosus, not just Sjögren's syndrome 3

Pulmonary Evaluation if Respiratory Symptoms Present

If the patient reports chronic cough or dyspnea: 1

  • High-resolution CT chest with expiratory views 1
  • Baseline pulmonary function tests 1
  • Oximetry testing at rest and with exercise 1

Chronic cough affects approximately 38% of patients with Sjögren's syndrome, and unexplained chronic cough with dry eyes led to Sjögren's diagnosis in 36% of previously undiagnosed patients. 1

References

Guideline

Sjögren's Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Indicators for Sjögren's Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sjogern's syndrome.

Seminars in cutaneous medicine and surgery, 2001

Guideline

Diagnosis and Management of Rheumatoid Arthritis with Secondary Sjögren's Syndrome Consideration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the clinical manifestations of Sjogren's syndrome?
What is the next step in managing a patient with suspected Sjogren's syndrome and positive Rheumatoid Factor (RF), but negative SS-A and SS-B autoantibodies and Antinuclear Antibodies (ANA) screen?
What is the most likely diagnosis for a patient with bilateral arthritis, arthralgia, severe dry eyes, and elevated Erythrocyte Sedimentation Rate (ESR), with a negative anti-SSA (Anti-Sjögren's Syndrome A) test?
What labs are necessary for a work-up of Sjögren's (Sjögren's syndrome) syndrome in a patient presenting with dry eyes, dry mouth, and decreased saliva production?
What is the diagnosis and management for a 75-year-old female with dry eyes and dry mouth, positive serum Antinuclear Antibody (ANA), SSA (Ro), SSB (La), and Centromere antibodies, but negative serum Double-Stranded DNA (dsDNA)?
Is it safe to mix linezolid and methylprednisolone through a Y-site (Y-site) connection or should they be administered separately?
What is the management for a patient with a burning sensation in the abdomen after ingesting a small amount of petrol (gasoline)?
What could be causing arm heaviness and weakness in a patient?
What is the best approach to manage pudendal neuralgia in a patient with chronic pain and significant impact on quality of life?
What is the recommended dose of prednisone (corticosteroid) for an adult patient with Immune Thrombocytopenic Purpura (ITP)?
What is the recommended dosage of Proton Pump Inhibitor (PPI) prophylaxis, such as pantoprazole (a type of PPI), in patients with acute liver failure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.